The same global food system that is fueling rising obesity rates is also accelerating climate change, according to a sweeping ...

Global pharma giants Eli Lilly and Novo Nordisk are scrambling to cement their lead in India's booming obesity drug market ...

Pharmaceutical giants like Lilly and Nordisk are battling for dominance in India’s weight-loss market with price cuts and ...

Expert Dr. Salas-Whalen reveals that body composition testing, not just the number on your scale, is key to knowing whether ...

The clinical trial showed this experimental medication to be much more effective than any existing GLP-1 drug. But that much ...

Analysts called the approval a much-needed win for Novo Nordisk, but warned that the company could struggle to grow sales once rival drugs come to market.

“Early intervention would be lifestyle change, and that can be extremely helpful, especially in younger adolescents who are ...

After ushering in a new era of obesity treatment with its GLP-1 medicine Wegovy earlier in the decade, Novo Nordisk is making ...

Paramount Skydance is putting some billionaire weight behind its embattled bid for Warner Bros. Discovery. Yesterday, ...

Until now, the most widely used GLP-1 medicines for weight loss have been injections. Novo Nordisk is pitching the newly approved Wegovy pill as a more convenient, once-daily option that could broaden ...

Mortality rates are high in patients with type 1 diabetes, and overweight and obesity appear to be major factors, a speaker ...

Host-Related Determinants of Immunotherapy Response in NSCLC may include obesity, sarcopenia, metabolic comorbidities, sex, ...